A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.
about
Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressantTreating comorbid anxiety and depression: Psychosocial and pharmacological approachesSchizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.Biomarkers for depression: recent insights, current challenges and future prospects.Investigational drugs in recent clinical trials for treatment-resistant depression.Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment.Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid in macaques following early life stress and inverse association with hippocampal volume: preliminary implications for serotonin-related function in mood and anxiety disorders.Rodent models of treatment-resistant depression.Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociabilityEfficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials.Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects.Decreased ribosomal DNA transcription in dorsal raphe nucleus neurons differentiates between suicidal and non-suicidal death.The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder.Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment.Posttraumatic Stress Disorder and Depression Symptom Severities Are Differentially Associated With Hippocampal Subfield Volume Loss in Combat VeteransPrefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment
P2860
Q26747727-270A5111-8590-4573-837B-3A54F8C45A7BQ26770334-F639B9B3-C951-422E-8DB8-418BCDB7E6A3Q30416883-FC89F225-0DE3-4322-B0CC-AB53C27BEB15Q33704099-C627220B-9940-4133-9EF8-8ECA39BBF64DQ34549390-B8312F53-B71D-4463-ADC4-E4914DE97154Q34556039-C128B77A-8EE8-4455-B670-6790F6EE3204Q34763406-2598B460-2CCD-4B44-B197-14EFB7968B6CQ35580361-97F7B0B9-404B-4784-9B72-C53C63ED23BAQ36023651-9A9DA937-D646-42BC-A5B0-6B726AA2274BQ36216847-2807E7B8-B252-4E76-9F83-51744BA97FFDQ36287901-B9FD6BBF-4CAE-4375-AF17-5E327935FAF4Q36762287-E55D165D-6B19-41DD-91C8-32EAEF1B5C7CQ38921265-367F0117-2AED-4627-8E70-5A976051D8A7Q47698260-0B7AE5DC-F37A-4552-92EA-6987E8760476Q58213313-74187DC7-F946-4CFC-BF64-0E8F36F36092Q58213868-931EDD9B-343C-4D44-B866-E488A015BBB5
P2860
A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A neurobiological hypothesis o ...... uptake inhibitor non-efficacy.
@ast
A neurobiological hypothesis o ...... uptake inhibitor non-efficacy.
@en
type
label
A neurobiological hypothesis o ...... uptake inhibitor non-efficacy.
@ast
A neurobiological hypothesis o ...... uptake inhibitor non-efficacy.
@en
prefLabel
A neurobiological hypothesis o ...... uptake inhibitor non-efficacy.
@ast
A neurobiological hypothesis o ...... uptake inhibitor non-efficacy.
@en
P2093
P2860
P356
P1476
A neurobiological hypothesis o ...... uptake inhibitor non-efficacy.
@en
P2093
Benjamin R Berry
Jeremy D Coplan
Srinath Gopinath
P2860
P356
10.3389/FNBEH.2014.00189
P577
2014-05-20T00:00:00Z